ClinicalTrials.gov
public full text
Public Domain
Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting
This is a randomized, double-blind, placebo-controlled trial to assess the efficacy of zinc in a higher risk COVID-19 positive outpatient population.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Zinc Supplementation and Infections in Older Medical Patients#1045221
- Impact of Daily Zinc Supplementation to Infants Born With Low Birth Weight on Death and Severe Disease#1114912
- Efficacy of Zinc in the Treatment of Pneumonia#981453
- Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India#1162039
- Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation#1047020
Record · ID 886491
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive